Navigation Links
Air Methods Corporation Confirms Mid-Air Collision in Arizona
Date:6/30/2008

DENVER, June 30 /PRNewswire/ -- Air Methods Corporation reported that a Bell 407 helicopter serving the Flagstaff Medical Center in Flagstaff, Arizona and another air medical helicopter, operated by a separate service provider, collided in mid-air yesterday at approximately 3:45 p.m. MDT. The patient, flight nurse, and pilot on board the Air Methods aircraft received fatal injuries.

Company officials have arrived or are en route to the area. Representatives from the Federal Aviation Administration and the National Transportation Safety Board are investigating the accident with full cooperation and support from the Company.

"We are deeply saddened by this tragic event and those lost on board both aircraft. We extend our heartfelt condolences to the members of their families," said Aaron Todd, chief executive officer of Air Methods Corporation.

CONTACTS: Aaron D. Todd, Chief Executive Officer, (303) 792-7413


'/>"/>
SOURCE Air Methods Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Newly approved ocular safety methods reduce animal testing
2. Air Methods to Present at the Jefferies 2nd Annual Healthcare Conference on June 24, 2008
3. Best Practices: Achieving Excellence in Staffing and Recruiting Methods
4. Methods and Tools Used to Achieve Best Customer Satisfaction
5. Population Health Impact Institute Releases Methods Evaluation Process(TM) (MEP(TM)) Accreditation Standards for Public Comment Period
6. Invasive methods unnecessary for prostate cancer radiation therapy treatment planning
7. Population Health Impact Institute to Host First Methods Evaluation Process(TM) (MEP(TM)) Workshop at Annual CMSA Conference
8. Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million
9. Air Methods Corporation Confirms Fatal Accident in Wisconsin
10. Air Methods Reports 1Q2008 Results and 2Q2008 Update
11. Air Methods to Report First Quarter Financial Results on Thursday, May 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... Guide ...      , No matter on which side of the Atlantic devicemakers do ... device regulations they have to follow. , In addition to the full text of ...
(Date:6/28/2017)... ... , ... Anyone with a remote control has seen the never-ending twists on the house flipping ... get rich in no time. But what about the buyers of the flipper's flip. ... of a flipped house. An email recently sent to Gary Case said, “Just closed ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... ... , ... American Farmer proudly announces the participation of Pure Line Seeds, Inc ... to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... seed. As demand grew, the small company located in Moscow, Idaho extended its sales ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: